177 related articles for article (PubMed ID: 12268911)
1. Survey shows practice sites prefer ON 7/7/7 for new patients.
Contracept Technol Update; 1987 Sep; 8(9):113. PubMed ID: 12268911
[TBL] [Abstract][Full Text] [Related]
2. ON 7/7/7 is first choice for 60% of CTU survey respondents.
Contracept Technol Update; 1987 Sep; 8(9):109-12. PubMed ID: 12268910
[TBL] [Abstract][Full Text] [Related]
3. Surveying outpatient services in the Southwest.
Rich M
AVSC News; 1989 Apr; 27(1):4, 6. PubMed ID: 12315715
[TBL] [Abstract][Full Text] [Related]
4. On 7/7/7 preferred for new patients by 47% of respondents.
Contracept Technol Update; 1986 Sep; 7(9):101-4. PubMed ID: 12268337
[TBL] [Abstract][Full Text] [Related]
5. Might generic OCs create contraceptive price war?
Contracept Technol Update; 1987 Feb; 8(2):13-7. PubMed ID: 12314977
[TBL] [Abstract][Full Text] [Related]
6. Pill, diaphragm costs vary by location, provider of services, clinics reveal.
Contracept Technol Update; 1984 Sep; 5(9):111. PubMed ID: 12339671
[TBL] [Abstract][Full Text] [Related]
7. Nurses, physicians prefer different postpartum prescription practices.
Contracept Technol Update; 1986 Sep; 7(9):108-9. PubMed ID: 12268336
[TBL] [Abstract][Full Text] [Related]
8. The social marketing of contraceptives in Mexico.
De La Macorra L
Dev Commun Rep; 1980 Jul; (31):3-4. PubMed ID: 12315136
[TBL] [Abstract][Full Text] [Related]
9. Three triphasic oral contraceptives now available in U.S.
Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
[TBL] [Abstract][Full Text] [Related]
10. Emergency contraception status report: work to do.
Contracept Technol Update; 1998 Mar; 19(3):33-4. PubMed ID: 12293272
[TBL] [Abstract][Full Text] [Related]
11. SOMARC witnesses CSM program launch in four countries.
Soc Mark Update; 1986; 6(2):1, 3-4. PubMed ID: 12280890
[TBL] [Abstract][Full Text] [Related]
12. Approaches vary in managing the over-40 pill patient.
Contracept Technol Update; 1988 Sep; 9(9):105-7. PubMed ID: 12342192
[TBL] [Abstract][Full Text] [Related]
13. Designating types of OCs in family planning agency can save money.
Contracept Technol Update; 1985 Jan; 6(1):6-7. PubMed ID: 12279917
[TBL] [Abstract][Full Text] [Related]
14. Clinics hard hit by drug price increases are focus of Senate hearing.
Wash Memo Alan Guttmacher Inst; 1991 Oct; (17):3-4. PubMed ID: 12284474
[TBL] [Abstract][Full Text] [Related]
15. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
American Health Consultants
Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
[TBL] [Abstract][Full Text] [Related]
16. Pill won't budge from no. 1 spot: half of women leave exams with OCs.
Contracept Technol Update; 2000 Sep; 21(9):101-4. PubMed ID: 12296239
[TBL] [Abstract][Full Text] [Related]
17. Young teens are safe on pills but need counseling, follow-up.
Contracept Technol Update; 1987 Sep; 8(9):120-2. PubMed ID: 12268914
[TBL] [Abstract][Full Text] [Related]
18. Ortho markets first FDA-approved triphasic pill.
Contracept Technol Update; 1984 Jun; 5(6):69-71. PubMed ID: 12313082
[TBL] [Abstract][Full Text] [Related]
19. School-based clinics combat teen pregnancy.
Contracept Technol Update; 1985 Apr; 6(4):53-7. PubMed ID: 12313867
[TBL] [Abstract][Full Text] [Related]
20. Depo-Provera: costs eat up clinic contraceptive budgets.
Contracept Technol Update; 1999 Jan; 20(1):1-3. PubMed ID: 12349019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
